Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 4
2005 2
2006 7
2007 6
2008 2
2009 2
2010 4
2011 9
2012 7
2013 10
2014 8
2015 5
2016 9
2017 5
2018 8
2019 8
2020 15
2021 22
2022 25
2023 25
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

172 results

Results by year

Filters applied: . Clear all
Page 1
Erfolgreiche Behandlung eines Checkpoint‐Inhibitor‐assoziierten bullösen Pemphigoids mit Dupilumab bei Angiosarkom: Successful treatment of checkpoint inhibitor‐associated bullous pemphigoid with dupilumab in a patient with angiosarcoma.
Hansen I, Gebhardt C, Booken N, Schneider SW. Hansen I, et al. Among authors: schneider sw. J Dtsch Dermatol Ges. 2024 Apr;22(4):587-590. doi: 10.1111/ddg.15340_g. J Dtsch Dermatol Ges. 2024. PMID: 38574016 German. No abstract available.
C-reactive protein flare predicts response to checkpoint inhibitor treatment in melanoma.
Kött J, Zimmermann N, Zell T, Heidrich I, Geidel G, Rünger A, Smit DJ, Merkle M, Parnian N, Hansen I, Hoehne I, Abeck F, Torster L, Weichenthal M, Pantel K, Schneider SW, Gebhardt C. Kött J, et al. Among authors: schneider sw. J Eur Acad Dermatol Venereol. 2024 Mar 11. doi: 10.1111/jdv.19941. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38466133
172 results